Inotropes and β-blockers: Is there a need for new guidelines?
- 30 September 2001
- journal article
- review article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 7 (2) , 8-12
- https://doi.org/10.1054/jcaf.2001.26655
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathyJournal of Clinical Investigation, 2001
- Low-dose enoximone improves exercise capacity in chronic heart failure∗∗A list of the Enoximone Study Group Members and institutional affiliations is provided in the appendix.Journal of the American College of Cardiology, 2000
- Myocardial-Directed Overexpression of the Human β1-Adrenergic Receptor in Transgenic MiceJournal of Molecular and Cellular Cardiology, 2000
- Early and Delayed Consequences of β 2 -Adrenergic Receptor Overexpression in Mouse HeartsCirculation, 2000
- Chronic Phospholamban–Sarcoplasmic Reticulum Calcium ATPase Interaction Is the Critical Calcium Cycling Defect in Dilated CardiomyopathyCell, 1999
- Progressive hypertrophy and heart failure in β 1 -adrenergic receptor transgenic miceProceedings of the National Academy of Sciences, 1999
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997
- Medical Therapy Can Improve the Biological Properties of the Chronically Failing HeartCirculation, 1996
- Effects of Levosimendan, a Cardiotonic Agent Targeted to Troponin C, on Cardiac Function and on Phosphorylation and Ca 2+ Sensitivity of Cardiac Myofibrils and Sarcoplasmic Reticulum in Guinea Pig HeartCirculation Research, 1995
- Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.Circulation Research, 1994